How to buy OPKO Health (OPK) shares in Australia
Learn how to easily invest in OPKO Health shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
OPKO Health Inc is a diagnostics & research business with stocks listed in the US. OPKO Health shares (OPK) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$4.53 – a decrease of 1.31% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in OPKO Health
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for OPKO Health. Find the share by name or ticker symbol: OPK. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until OPKO Health reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$4.28, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of OPKO Health, depending on your broker.
- Check in on your investment. Congratulations, you own a part of OPKO Health. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
OPKO Health stock price (NASDAQ:OPK)Use our graph to track the performance of OPK stocks over time.
OPKO Health shares at a glance
|52-week range||US$3.26 - US$6.27|
|50-day moving average||US$4.2984|
|200-day moving average||US$3.9278|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$0.118|
Where to buy OPKO Health stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy OPKO Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
OPKO Health price performance over time
|1 week (2022-01-12)||2.03%|
|1 month (2021-12-17)||2.72%|
|3 months (2021-10-19)||20.80%|
|6 months (2021-07-19)||28.33%|
|1 year (2021-01-19)||-0.22%|
|2 years (2020-01-17)||190.38%|
|3 years (2019-01-18)||19.21%|
|5 years (2017-01-19)||-48.23%|
Stocks similar to OPKO Health
Is OPKO Health under- or over-valued?
Valuing OPKO Health stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of OPKO Health's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
OPKO Health's P/E ratio
OPKO Health's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 38x. In other words, OPKO Health shares trade at around 38x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
OPKO Health's EBITDA
OPKO Health's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$178.6 million (£0.0 million).
The EBITDA is a measure of a OPKO Health's overall financial performance and is widely used to measure a its profitability.
OPKO Health financials
|Revenue TTM||US$1.9 billion|
|Operating margin TTM||5.3%|
|Gross profit TTM||US$465.7 million|
|Return on assets TTM||2.58%|
|Return on equity TTM||4.48%|
|Market capitalisation||US$3.1 billion|
TTM: trailing 12 months
OPKO Health share dividends
We're not expecting OPKO Health to pay a dividend over the next 12 months.
OPKO Health share price volatility
Over the last 12 months, OPKO Health's shares have ranged in value from as little as US$3.26 up to US$6.27. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while OPKO Health's is 1.7319. This would suggest that OPKO Health's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
OPKO Health overview
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers and governmental units, as well as 4Kscore prostate cancer testing services. The company's Pharmaceutical segment offers Rayaldee for treatment for secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and associated obesity that is in Phase IIb trials; and hGH-CTP, a once-weekly human growth hormone injection that completed Phase III clinical trial in partnership with Pfizer, Inc. This segment develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins. It also specialty active pharmaceutical ingredients; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and imports, markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. In addition, the company operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. OPKO Health, Inc. was incorporated in 1991 and is headquartered in Miami, Florida.
OPKO Health in the news
OPKO HEALTH, INC. : Entry into a Material Definitive Agreement (form 8-K)
Aries Wealth Management Buys SPDR Portfolio Short Term Treasury ETF, Microsoft Corp, Vanguard ...
360 Financial, Inc. Buys Global X U.S. Infrastructure Development ETF, AMMO Inc, Vanguard ...
Frequently asked questions
More guides on Finder
RAT scams: How to avoid getting conned with rapid antigen tests
Don't fall for the scam artists when you're trying to protect your health - here's what to check.
How to do a COVID-19 test at home for international travel
Here's where you can book COVID-19 at-home tests approved for travel and how they work.
Where to shop every product in Kiernan Shipka’s beauty routine
We've rounded up everything you need to nail the 'date-worthy' makeup look, including some affordable dupes.
American Express Corporate Gold Card
Designed for big companies, this Amex charge card offers a mix of management tools and perks – including a 100,000 bonus Membership Rewards offer.
Rapid antigen tests: When will RAT stock be available? [UPDATED]
Rapid antigen tests are proving extremely hard to find, but there are options if you can be patient trying to find a RAT.
Beauty Product of the Week: Milk Makeup Hydro Grip Primer
We tried the viral Milk Makeup Hydro Grip Primer and spoiler alert, it's the bee's knees.
Where to watch Hotel Transylvania 4 online for free in Australia
Drac and the Pack are back, like you’ve never seen them before.
Dyson V12 Detect Slim review: Baby love, my baby love
A delightful compact vacuum with an unjustifiable price.
Stan Event: Streaming platform joins pay-per-view ranks
A new player enters the Australian sports broadcast market.
Amazon Echo Buds (2nd Gen) review: Fine if you’re already trapped by Bezos
The Amazon Echo Buds 2 are a solid addition to your earholes if you’re already integrated in the Alexa ecosystem. But if you’re not, its hard to find anything here that really stands out.
Ask an Expert